Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Tackling Unmet Needs with a Proprietary Platform

Posted on November 22nd, 2018 by

Since our founding back in 2006, LegoChem Biosciences (LCB) has focused on the research and development of anti-biotic, anti-coagulant, anti-fibrosis and Antibody-Drug Conjugate (ADC) therapeutics based on our proprietary platform technology, LegoChemistry™ & Conjuall™. LCB is comprised of researchers who have varied backgrounds and R&D experiences, including the development of Factive, the first US FDA-approved drug developed in Korea. (more…)

Leveraging Partnerships to Rescue and Develop Promising Technologies

Posted on November 14th, 2018 by

There are a number of players in the field of innovative therapeutics for cancer and inflammatory disease, but our company, 4P-Pharma, is taking a somewhat different approach than most of our competition. (more…)

Rapid Growth and Promising Partnerships

Posted on October 11th, 2018 by

Beacon Discovery is a science-focused company with a huge breadth of experience in discovering and developing drugs that target G-Protein Coupled Receptors (GPCRs) – and, in the two years since our founding in September 2016, we have already achieved some important milestones. (more…)

Finding Support and Success Along the Development Path

Posted on September 28th, 2018 by

The Hive
We founded 4P-Pharma at the end of 2014 in response to the urgent need to increase the number of innovative therapeutics entering the developing drug pipeline for cancer and inflammatory diseases. Our idea was to detect the most promising technologies (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 9